(Q33522776)

27 July 2017

title

The cost of relapse and the predictors of relapse in the treatment of schizophrenia (English)

1 reference

27 July 2017

0 references

1

Haya Ascher-Svanum

1 reference

27 July 2017

7

Robert R Conley

1 reference

27 July 2017

Baojin Zhu

2

1 reference

27 July 2017

Douglas E Faries

3

1 reference

27 July 2017

David Salkever

4

1 reference

27 July 2017

Eric P Slade

5

1 reference

27 July 2017

Xiaomei Peng

6

1 reference

27 July 2017

language of work or name

1 reference

7 January 2010

1 reference

27 July 2017

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

page(s)

2

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

copyright license

start time

7 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-244x-10-2

0 references

cites work

Understanding and addressing adherence issues in schizophrenia: from theory to practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Outpatient antipsychotic treatment and inpatient costs of schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Cost of disorders of the brain in Europe

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Predictability of prescription drug expenditures for Medicare beneficiaries.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Relapse in schizophrenia: costs, clinical outcomes and quality of life

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Estimation of antipsychotic effects on hospitalization risk in a naturalistic study with selection on unobservables

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Using drug claims data to assess the relationship of medication adherence with hospitalization and costs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Adjusting capitation rates using objective health measures and prior utilization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

DRG benchmarking study establishes national coding norms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Cost of relapse in schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

The positive and negative syndrome scale (PANSS) for schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Resource-based relative values. An overview

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

A New Depression Scale Designed to be Sensitive to Change

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-2

The Schizophrenia Care and Assessment Program Health Questionnaire (SCAP-HQ): an instrument to assess outcomes of schizophrenia care

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-2

Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-2

Mental health in the Medicare Part D drug benefit: a new regulatory model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-2

A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Medicare capitation payments to HMOs in light of regression toward the mean in health care costs.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817695

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20059765

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-244X-10-2

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference